ARNA


Arena Pharmaceuticals Soars 80.4% on Pfizer’s $6.7B Acquisition Deal

This article was originally published on TipRanks.com.

Arena Posts Worse-Than-Feared Quarterly Loss As Sales Disappoint

Arena Pharmaceuticals posted a wider-than-expected loss in the fourth quarter, as the biopharmaceutical company’s sales were almost negligible. Shares declined about 2.

These 3 Cannabis Stocks Are Set to Skyrocket, Say Analysts

The cannabis market is buzzing right now. But the recent rally in cannabis stocks has left some of the bigger names looking overvalued.

Arena Pharmaceuticals, Inc. (ARNAׁ) Stock Has More Upside Ahead: Cantor

It’s a big day for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).

Arena Pharmaceuticals, Inc. (ARNA) Makes the Street Go Wild on Back of Positive Phase 2 Ulcerative Colitis Data

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares are shooting up 35% faster than Jack’s magic bean sparking right into a giant beanstalk.

A Glimpse Into Two Climbing Biotechs: Arena Pharmaceuticals, Inc. (ARNA) and Ocular Therapeutix Inc (OCUL)

Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc.

Biotech Beat: Arena Pharmaceuticals, Inc. (ARNA) and Exelixis, Inc. (EXEL)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) investors have a smile on their faces Monday evening, after the drug maker announced positive Phase 2 results for …

Arena Pharmaceuticals, Inc. (ARNA) Tanks on Share Dilution

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in …

FBR Reiterates Buy On Arena Pharmaceuticals, Inc. (ARNA) Following 4Q16 Update

In a research report published Wednesday, FBR analyst Rahul Jasuja reiterated an Outperform rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) with a …

Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Announces 4Q and Full-Year 2016 Financial Results

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the fourth quarter and full-year ended December 31, 2016 and provided a corporate update.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts